Semprana (dihydroergotamine oral inhalation) - AbbVie
Allergan: Q4 2015 Results (Allergan) - Feb 23, 2016 - Anticipated NDA submission in US for acute migraine in H2 2016 
Anticipated NDA Migraine
http://www.allergan.com/investors/events-presentations/events/q4-2015-allergan-plc-earnings-conference-call
 
Feb 23, 2016
 
.
 
63a7553e-5a8e-4b06-be73-74f71851cd4b.jpg